Clinical Trials Logo

Autism clinical trials

View clinical trials related to Autism.

Filter by:

NCT ID: NCT04859998 Enrolling by invitation - Clinical trials for Autism Spectrum Disorder

Effects of Animal-assisted Therapy on the Physical Function and Communication of Adults With Autism

Start date: April 26, 2021
Phase: N/A
Study type: Interventional

The aim is to evaluate the effects of a dog-assisted therapy program on physical function and communication in a sample comprised of 24 adults with autism spectrum disorder. The sample will be divided into 2 groups, a control group and an experimental group. Changes after 10 weeks (20 sessions) will be compared between-groups.

NCT ID: NCT04840498 Completed - Autism Clinical Trials

UAB AIM Virtual Magic Camp

Start date: April 7, 2021
Phase:
Study type: Observational

The magic camp for children with disabilities at UAB has been conducted yearly since 2018. This year, because of the Covid-19, the magic camp will be conducted online. The virtual magic camp will start in the beginning of June . It will run for 4 weeks. After one cohort, there will be another cohort starts in the beginning of July . Each cohort will have about 30 children with disabilities. Two occupational therapy graduate students will teach each child via Zoom to learn magic hand trick 3 times a week, one hour each. No studies evaluate the psychological benefits of learning magic tricks via online in children with disabilities. Therefore, this study is to evaluate the psychological being of the children participants after completing a virtual magic camp.

NCT ID: NCT04838912 Completed - Anxiety Clinical Trials

Testing a CBT Program for Anxiety in Teenagers With Autism: A Feasibility Study

Start date: June 1, 2021
Phase: N/A
Study type: Interventional

The objective is to investigate the feasibility of a newly developed manualised group Cognitive Behavioural Therapy (CBT) programme for anxiety in 15 teenagers (aged 13-17 years) with Autism Spectrum Disorder (ASD). Our aim is to focus primarily on acceptability and compliance with the program with some investigation of treatment effects on anxiety diagnosis and anxiety symptoms.

NCT ID: NCT04805957 Enrolling by invitation - Clinical trials for Autism Spectrum Disorder

Validation Digital Bio-markers During Sulforaphane Treatment.

Start date: July 7, 2022
Phase: N/A
Study type: Interventional

The purpose of the research is to determine if changes seen during sulforaphane treatment (a compound that comes from eating certain vegetables) can better be understood using digital biomarkers. These digital biomarkers are things like heart rate, muscle movement etc. and are measured using non-invasive devices (like a watch) and are aimed at complementing the traditional clinical scores already in use in current trials (e.g. Aberrant Behavior Checklist (ABC), Social Responsiveness Scale (SRS) and Ohio Autism Clinical Impressions Scale (OACIS)).

NCT ID: NCT04788537 Completed - Clinical trials for Autism Spectrum Disorder

Services to Enhance Social Functioning in Adults With Autism Spectrum Disorders

Start date: February 16, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to test a novel, three-part cognitive behavioral treatment strategy to improve social functioning in adults with autism spectrum disorder. The treatment, named TUNE In (Training to Understand and Navigate Emotions and Interactions), includes components to address the many behavioral domains involved in social functioning, including social motivation, social anxiety, social cognition, social skills, and generalization of the skills to community settings. The Investigators will test the efficacy of TUNE In to improve social functioning in adults with autism spectrum disorder (ASD), using a randomized controlled trial using the SRS-2 as the primary outcome measure.

NCT ID: NCT04771338 Completed - Clinical trials for Autism Spectrum Disorder

Examining the Effects of a Job Entry Intervention

IMPRESSIVE
Start date: September 1, 2019
Phase: N/A
Study type: Interventional

The current study will examine the efficacy of a virtual reality (VR) intervention as well as a newly developed Kessler Foundation STRength IDentification and Expression tool (VR-STRIDE) with adolescents diagnosed with autism spectrum disorder.

NCT ID: NCT04766177 Recruiting - Autism Clinical Trials

Role of Bumetanide in Treatment of Autism

Start date: January 1, 2021
Phase: Phase 3
Study type: Interventional

Role of bumetanide in Autism

NCT ID: NCT04746027 Completed - Autism Clinical Trials

Empathy, Psychopathy and Autism: Behavioural Associations and the Role of an Oxytocin Receptor Polymorphism in a Non-clinical Adult Population

Start date: July 1, 2017
Phase:
Study type: Observational

This is an investigation into the associations between psychopathic traits, autistic traits and empathy (cognitive and affective) in the general population as measured using three self report questionnaires and one behavioural task. Participants will also be genotyped for OXTR rs53576 to assess whether this mutation associates with any of the behavioural traits investigated.

NCT ID: NCT04739982 Recruiting - Clinical trials for Autism Spectrum Disorder

Evaluating Efficacy of GuessWhat Mobile App Therapy for Children With Autism

Start date: July 7, 2021
Phase: N/A
Study type: Interventional

The following study aims to understand the efficacy of the mobile game platform, GuessWhat, in delivering behavioral therapy to children with Autism Spectrum Disorder (ASD). GuessWhat is a mobile application (available for free for iOS and Android) which contains a suite of games: pro-social charades, emotion guessing, and quiz. Participant families will use their personal smartphones to download the app and play it with their child according to a predetermined regimen.

NCT ID: NCT04630847 Not yet recruiting - Clinical trials for Autism Spectrum Disorder

Familial Fecal Microbiota Transplant for the Treatment of Subjects With Autism Spectrum Disorders

Start date: May 2022
Phase: Phase 1
Study type: Interventional

This is an open-label clinical trial to evaluate the benefits of familial fecal microbiota transplant following a 6-week treatment with Vancomycin in minor and adult subjects with ASD for treatment of social deficits and language delays.